+499.5%
MRNA vs EXEL
+59.2%
+440.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EXEL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.2% | -2.0% | -2.0% |
| 7D | +5.5% | +8.4% | -2.9% | -1.9% |
| 30D | +158.7% | +4.1% | +154.7% | +148.9% |
| 3M | +182.1% | +12.4% | +169.7% | +162.3% |
| 6M | +151.8% | +41.5% | +110.3% | +112.0% |
| YTD | +393.6% | +34.6% | +358.9% | +321.1% |
| 1Y | +499.5% | +57.9% | +441.6% | +401.6% |
| All | +499.5% | +59.2% | +440.2% | +401.6% |
Cumulative growth
Daily Returns
Daily percentage return beside EXEL.
Daily Out/Under-Performance
Portfolio return minus EXEL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EXEL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EXEL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling